-
Arbor receives $35 million in financing
ATLANTA Drug maker Arbor Pharmaceuticals has obtained nearly $35 million in financing, the company said Thursday.
Arbor said the $34.8 million included a $17.5 million investment in the form of Series B Preferred Stock, mostly from Signet Healthcare Partners, while the rest was in the form of a loan provided by investors, as well as portions of the loan and investment from existing shareholders. The company markets drugs for such indications as nasal hygiene and dermatitis.
-
Flu cards just tip of functioning health-reform iceberg
WHAT IT MEANS AND WHY IT'S IMPORTANT — There currently are about 1,200 retail clinics and more than 100,000 certified immunizing pharmacists. Expect those numbers to rise steadily as other employers looks to mimic Citi's free flu shot card program -- and you can bet they will.
(THE NEWS: Citi's flu care card pushes employers toward lower-cost retail channels. For the full story, click here)